Modeling the impact of prostate edema on LDR brachytherapy: a Monte Carlo dosimetry study based on a 3D biphasic finite element biomechanical model

Abstract

Prostate volume changes due to edema occurrence during transperineal permanent brachytherapy should be taken under consideration to ensure optimal dose delivery. Available edema models, based on prostate volume observations, face several limitations. Therefore, patient-specific models need to be developed to accurately account for the impact of edema. In this study we present a biomechanical model developed to reproduce edema resolution patterns documented in the literature. Using the biphasic mixture theory and finite element analysis, the proposed model takes into consideration the mechanical properties of the pubic area tissues in the evolution of prostate edema. The model's computed deformations are incorporated in a Monte Carlo simulation to investigate their effect on post-operative dosimetry. The comparison of Day1 and Day30 dosimetry results demonstrates the capability of the proposed model for patient-specific dosimetry improvements, considering the edema dynamics. The proposed model shows excellent ability to reproduce previously described edema resolution patterns and was validated based on previous findings. According to our results, for a prostate volume increase of 10-20% the Day30 urethra D10 dose metric is higher by 4.2%-10.5% compared to the Day1 value. The introduction of the edema dynamics in Day30 dosimetry shows a significant global dose overestimation identified on the conventional static Day30 dosimetry. In conclusion, the proposed edema biomechanical model can improve the treatment planning of transperineal permanent brachytherapy accounting for post-implant dose alterations during the planning procedure.

A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma

“…Limitations of our study include the small sample size, the lack of a control population, and the very small numbers of patients treated at each immunotherapy dose, precluding a final judgement on the optimal dosing of immunotherapy in this setting. Because of regulatory requirements and the limited number of patients we were unable to investigate other radiation dosimetry methods 18 , 19 that may hold promise for decreasing toxicity. The bispecific antibody tenbendafusp has recently been shown in a controlled trial 20 to improve survival in patients with metastatic uveal melanoma who are positive for HLA-A2.…”

DVH-Based Inverse Planning Using Monte Carlo Dosimetry for LDR Prostate Brachytherapy

“…This will be addressed by introducing within the optimization process a previously developed biomechanical model for edema prediction. 44 Additionally, in future work, we aim to evaluate the proposed methodology in a clinical setting. Therefore, we have developed the inverse planning software TiTAN based on the proposed DVH-FSA algorithm.…”

Standardization and Validation of Brachytherapy Seeds’ Modelling Using GATE and GGEMS Monte Carlo Toolkits

“…Several GPU-accelerated MC engines, for dosimetric studies, have been proposed by different groups already [ 23 , 24 , 25 , 26 ]. The GGEMS toolkit [ 20 , 24 ] is a GPU accelerated MC dose engine based on the Geant4 physics models and has been used for dosimetry applications in prostate brachytherapy procedures [ 24 , 27 , 28 , 29 ]. In the present study, we evaluated the ability of GGEMS to provide accurate dosimetric data in a brachytherapy scenario using the Amersham, Oncoseed, 6711 type.…”